Batch: GF112025092 Key analytical results include: BPC-157 Assay Content: 15.51 mg BPC-157 Identification Retention Time: 0.997 TB-500 (Thymosin Beta-4) Assay Content: 15.41 mg TB-500 Identification Retention Time: 0.989 Bacterial Endotoxins: below 0.001 EU per mg Total Aerobic Microbial Count: not detected Total Yeast and Mold Count: not detected Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium
Consta de 15 aminocidos (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val) y est ampliamente estudiado en modelos preclnicos para reparacin tisular, angiognesis, gastroproteccin y curacin de tendones y ligamentos
Pharmacokinetic studies have also not been conducted in people with hepatic impairment
Andreeff M , Carter B, Konopleva M, Zhao S, Tsao T, Weidner D, Estey E, Lopez-Berestein G, Estrov Z, Altieri D, Kornblau SM, Reed JC
Epigenetic regulation through histone deacetylation: implications and therapeutic potential in hepatocellular carcinoma
Systemic distribution: Unlike BPC-157 which acts locally near the injection site, TB-500 distributes systemically through the body, which is why it addresses multi-site injuries and broader tissue repair needs
